EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Factors influencing the initiation of biologic therapy in children with severe asthma: Results of the pediatric asthma noninvasive diagnostic approaches (PANDA) study

Yoni E van Dijk iD, Milou A Brandsen, Simone Hashimoto iD, Niels W Rutjes, Kornel Golebski, Frederique Vermeulen, Suzanne W J Terheggen-Lagro iD, Bart E van Ewijk, Anke-Hilse Maitland-van der Zee, Susanne J H Vijverberg iD

Pediatric Pulmonology · 2024

DOI: 10.1002/ppul.27145 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Pulmonology, 2024. Verfasst von Yoni E van Dijk und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Pulmonology and Allergy, Emma Children's Hospital, Amsterdam UMC, Amsterdam, The Netherlands. Hauptthemen laut MEDLINE: Asthma, Biological Products. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Lung Foundation Netherlands.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background & objectives Despite the availability of biologics for severe pediatric asthma, real‐life studies reporting on drivers behind initiating biologics and their alignment with the Global Initiative for Asthma (GINA) recommendations are lacking.

Methods

We performed analysis within the pediatric asthma noninvasive diagnostic approaches study, a prospective cohort of 6‐ to 17‐year‐old children with severe asthma. Information was collected on demographic factors, symptom control, treatment, comorbidities, and diagnostic tests from medical records and questionnaires. We divided patients into “starters” or “nonstarters” based on the clinical decision to initiate biologics and performed multivariate logistic regression analysis to identify drivers behind initiating therapy. Additionally, we assessed patient suitability for biologics according to key factors in the GINA recommendations: Type 2 inflammation, frequency of exacerbations, and optimization of treatment adherence.

Results

In total, 72 children (mean age 11.5 ± 3.0 years, 65.3% male) were included (13 starters). Initiation of biologics was associated with a higher GINA treatment step (adjusted odds ratio's [aOR] = 5.0, 95%CI 1.33–18.76), steroid toxicity (aOR = 21.1, 95%CI 3.73–119.91), frequency of exacerbations (aOR = 1.6, 95%CI 1.10–2.39), improved therapy adherence (aOR = 1.7, 95%CI 1.10–2.46), Caucasian ethnicity (aOR = 0.20, 95%CI 0.05–0.80), ≥1 allergic sensitization (aOR = 0.06, 95%CI 0.004–0.97), and allergic rhinitis (aOR = 0.13, 95%CI 0.03–0.65). Furthermore, steroid toxicity was identified as an important factor for deviation from the current recommendations on biologic prescription.

Conclusions

We identified multiple drivers and inhibitors for initiating biologics, and showed the clinical need for biologics in severe pediatric asthmatics suffering from steroid toxicity. These findings may help refine asthma management guidelines.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AsthmaBiological ProductsHumansChildMaleFemaleAdolescentProspective StudiesBiological TherapyAnti-Asthmatic AgentsSeverity of Illness Index

Stichwörter der Autor:innen

asthma managementbiologicclinical practicereal‐life studysevere pediatric asthmatherapy adjustment

Substanzen

Biological ProductsAnti-Asthmatic Agents

Autor:innen und Institutionen

  • Department of Pediatric Pulmonology and Allergy, Emma Children's Hospital, Amsterdam UMC, Amsterdam, The Netherlands.
  • Department of Pulmonary Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
  • Amsterdam Institute for Infection and Immunity, Amsterdam, the Netherlands.
  • Amsterdam Public Health, Amsterdam, the Netherlands.
  • Department of Pediatric Medicine, Tergooi Medical Center, Hilversum, The Netherlands.

ORCID-Profile: Yoni E van Dijk, Simone Hashimoto, Suzanne W J Terheggen-Lagro, Susanne J H Vijverberg

Förderung

  • Lung Foundation Netherlands

Zitieren

APA

van Dijk, Y. E., Brandsen, M. A., Hashimoto, S., Rutjes, N. W., Golebski, K., Vermeulen, F., Terheggen-Lagro, S. W. J., van Ewijk, B. E., der Zee, A. M., & Vijverberg, S. J. H. (2024). Factors influencing the initiation of biologic therapy in children with severe asthma: Results of the pediatric asthma noninvasive diagnostic approaches (PANDA) study. Pediatric Pulmonology. https://doi.org/10.1002/ppul.27145

Vancouver

van Dijk YE, Brandsen MA, Hashimoto S, Rutjes NW, Golebski K, Vermeulen F, et al. Factors influencing the initiation of biologic therapy in children with severe asthma: Results of the pediatric asthma noninvasive diagnostic approaches (PANDA) study. Pediatric Pulmonology. 2024. doi:10.1002/ppul.27145

BibTeX
@article{vanDijk2024,
  author = {van Dijk, Yoni E and Brandsen, Milou A and Hashimoto, Simone and Rutjes, Niels W and Golebski, Kornel and Vermeulen, Frederique and Terheggen-Lagro, Suzanne W J and van Ewijk, Bart E and der Zee, Anke-Hilse Maitland-van and Vijverberg, Susanne J H},
  title = {Factors influencing the initiation of biologic therapy in children with severe asthma: Results of the pediatric asthma noninvasive diagnostic approaches (PANDA) study},
  journal = {Pediatric Pulmonology},
  year = {2024},
  doi = {10.1002/ppul.27145}
}
Kostenlos starten →